Effects of levosimendan in patients with left ventricular hypertrophy undergoing aortic valve replacement

Acta Anaesthesiologica Scandinavica

Volumn 59, Issue 1, 2015, Pages 65-77

  Juhl Olsen, P ^a,b   Jakobsen, C J ^a   Rasmussen, L A ^a   Bhavsar, R ^a   Klaaborg, K E ^a   Frederiksen, C A ^a,b   Sloth, E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOSIMENDAN; PLACEBO; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

AGED; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC HEART FUNCTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INFUSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; INTRAOPERATIVE PERIOD; LONGITUDINAL STUDY; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC HEART FUNCTION; AORTA VALVE; DRUG EFFECTS; HEART VALVE REPLACEMENT; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SURGERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; HYDRAZONES; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIDAZINES;

EID: 84916233393     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12425     Document Type: Article

References (34)

1. Mehta RH, Bruckman D, Das S, Tsai T, Russman P, Karavite D, Monaghan H, Sonnad S, Shea MJ, Eagle KA, Deeb GM,. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 2001; 122: 919-928.
2. Weiner MM, Reich DL, Lin HM, Krol M, Fischer GW,. Influence of increased left ventricular myocardial mass on early and late mortality after cardiac surgery. Br J Anaesth 2013; 110: 41-46.
3. Garcia D, Camici PG, Durand LG, Rajappan K, Gaillard E, Rimoldi OE, Pibarot P,. Impairment of coronary flow reserve in aortic stenosis. J Appl Physiol 2009; 106: 113-121.
4. Ukkonen H, Saraste M, Akkila J, Knuuti J, Karanko M, Iida H, Lehikoinen P, Nagren K, Lehtonen L, Voipio-Pulkki LM,. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000; 68: 522-531.
5. Järvelä K, Maaranen P, Sisto T, Ruokonen E,. Levosimendan in aortic valve surgery: cardiac performance and recovery. J Cardiothorac Vasc Anesth 2008; 22: 693-698.
6. Lahtinen P, Pitkanen O, Polonen P, Turpeinen A, Kiviniemi V, Uusaro A,. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. Crit Care Med 2011; 39: 2263-2270.
7. De Luca L, Sardella G, Proietti P, Battagliese A, Benedetti G, Di Roma A, Fedele F,. Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study. J Am Soc Echocardiogr 2006; 19: 172-177.
8. Jörgensen K, Bech-Hanssen O, Houltz E, Ricksten SE,. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis. Circulation 2008; 117: 1075-1081.
9. Eriksson HI, Jalonen JR, Heikkinen LO, Kivikko M, Laine M, Leino KA, Kuitunen AH, Kuttila KT, Perakyla TK, Sarapohja T, Suojaranta-Ylinen RT, Valtonen M, Salmenpera MT,. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg 2009; 87: 448-454.
10. Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M,. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. Eur J Heart Fail 2007; 9: 75-82.
11. Leppikangas H, Jarvela K, Sisto T, Maaranen P, Virtanen M, Lehto P, Karlsson S, Koobi T, Lindgren L,. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth 2011; 106: 298-304.
12. Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R,. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol 2012; 17: 125-130.
13. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ,. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007; 104: 766-773.
14. Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, Tanus E, del Mazo CD,. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome]. Rev Esp Cardiol 2008; 61: 471-479.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W,. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
16. Delgado V, Tops LF, van Bommel RJ, van der Kley F, Marsan NA, Klautz RJ, Versteegh MI, Holman ER, Schalij MJ, Bax JJ,. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J 2009; 30: 3037-3047.
17. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB,. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713. quiz 786-688.
18. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A,. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165-193.
19. Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, Tschope C,. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 2007; 116: 637-647.
20. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH III, Zoghbi WA, Quinones MA,. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999; 99: 254-261.
21. Hessel MH, Michielsen EC, Atsma DE, Schalij MJ, van der Valk EJ, Bax WH, Hermens WT, van Dieijen-Visser MP, van der Laarse A,. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp Mol Pathol 2008; 85: 90-95.
22. Mair J, Hammerer-Lercher A, Puschendorf B,. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39: 571-588.
23. Schmidt M, Maeng M, Jakobsen CJ, Madsen M, Thuesen L, Nielsen PH, Botker HE, Sorensen HT,. Existing data sources for clinical epidemiology: The Western Denmark Heart Registry. Clin Epidemiol 2010; 2: 137-144.
24. Toller W, Algotsson L, Guarracino F, Hormann C, Knotzer J, Lehmann A, Rajek A, Salmenpera M, Schirmer U, Tritapepe L, Weis F, Landoni G,. Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth 2013; 27: 361-366.
25. Kivikko M, Antila S, Eha J, Lehtonen L, Pentikainen PJ,. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure. J Clin Pharmacol 2002; 42: 43-51.
26. Algranati D, Kassab GS, Lanir Y,. Why is the subendocardium more vulnerable to ischemia? A new paradigm. Am J Physiol Heart Circ Physiol 2011; 300: H1090-1100.
27. Kivikko M, Lehtonen L, Colucci WS,. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003; 107: 81-86.
28. Zangrillo A, Biondi-Zoccai G, Mizzi A, Bruno G, Bignami E, Gerli C, De Santis V, Tritapepe L, Landoni G,. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009; 23: 474-478.
29. Axelsson B, Johansson G, Abrahamsson P, Gupta A, Tyden H, Wouters P, Haney M,. Milrinone and levosimendan during porcine myocardial ischemia-no effects on calcium overload and metabolism. Acta Anaesthesiol Scand 2013; 57: 719-728.
30. Girerd N, Magne J, Pibarot P, Voisine P, Dagenais F, Mathieu P,. Postoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study. BMJ Open 2011; 1: e000385.
31. Saxena A, Shi WY, Bappayya S, Dinh DT, Smith JA, Reid CM, Shardey GC, Newcomb AE,. Postoperative atrial fibrillation after isolated aortic valve replacement: a cause for concern? Ann Thorac Surg 2013; 95: 133-140.
32. Weiner MM, Reich DL, Lin HM, Krol M, Fischer GW,. Increased left ventricular myocardial mass is associated with arrhythmias after cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27: 292-297.
33. Levy F, Debry N, Labescat AL, Meimoun P, Malaquin D, Marechaux S, Rusinaru D, Jeu A, Ennezat PV, Castel AL, Tribouilloy C,. Echocardiographic prediction of postoperative atrial fibrillation after aortic valve replacement for aortic stenosis: a two-dimensional speckle tracking left ventricular longitudinal strain multicentre pilot study. Arch Cardiovasc Dis 2012; 105: 499-506.
34. Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, Almahameed S, Schweikert RA, Saliba WI, Gillinov AM, Tang WH, Mills RM, Francis GS, Young JB, Natale A,. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004; 110: 124-127.